US 9211409 — Patent Expiration

METHODS AND SYSTEMS FOR REDUCING INFLAMMATION BY NEUROMODULATION OF T-CELL ACTIVITY

Shareable link — bookmark or send to anyone

www.patentreply.ai/tools/patent-expiration/US9211409

Important: This calculator does not include patent term extension under 35 U.S.C. § 156, which may apply to certain drug, biologic, animal drug, and medical device patents.

Learn more about PTE and patent expiration

US 9211409

Methods And Systems For Reducing Inflammation By Neuromodulation Of T-cell Activity

High Confidence

Application No. 12415671

February 14, 2031

4y 240d remaining

Earliest effective filing

Mar 31, 2009

+ 20 years

Mar 31, 2029

PTA +685d

Feb 14, 2031

No TD

—

Final

Feb 14, 2031

This calculation includes Patent Term Adjustment (PTA) under 35 U.S.C. §154(b). Patent Term Extension (PTE) under 35 U.S.C. §156 (for FDA-regulated products) is not included.

Calculation Details

Base Term Calculation

Filing Date

March 31, 2009

Earliest Effective Filing

March 31, 2009

Issue Date

December 15, 2015

PTA

+685 days

Base Expiry (before PTA)

March 31, 2029

March 31, 2009 + 20 years = March 31, 2029 + 685 PTA days = February 14, 2031

PRO

61072603 — Provisional — not used for base term

Terminal Disclaimer Analysis

No TD

0 approved, 0 filed

Data sourced from public USPTO records. This tool provides informational estimates and should not be relied upon as legal advice. Always verify patent expiration dates independently, especially where patent term extension, terminal disclaimers, or unusual continuity issues may apply.